Coherus BioSciences
CHRS
$2.05
Share price
0.49%
Change (1 day)
-71.65%
Change (1 year)
Categories
Coherus BioSciences (CHRS) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.82 B
According to Coherus BioSciences 's latest financial reports the company's total liabilities are $0.82 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Coherus BioSciences - Total liabilities on balance sheet (from 2013 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $0.61 B | 6.3% |
| 2021-12-31 | $0.58 B | 3.73% |
| 2020-12-31 | $0.56 B | 84.61% |
| 2019-12-31 | $0.30 B | 119.99% |
| 2018-12-31 | $0.13 B | 4.53% |
| 2017-12-31 | $0.13 B | -17% |
| 2016-12-31 | $0.15 B | -27.44% |
| 2015-12-31 | $0.21 B | 82.06% |
| 2014-12-31 | $0.12 B | 34.1% |
| 2013-12-31 | $89.82 M | 418.02% |
| 2012-12-31 | $17.34 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $90.92 B | 10,947.24% | 🇺🇸 USA |
 Repligen
RGEN | $0.85 B | 3.67% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | $0.26 B | -67.62% | 🇺🇸 USA |